U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. More Details
Excellent balance sheet with acceptable track record.
Share Price & News
How has U.S. Physical Therapy's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: USPH is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: USPH's weekly volatility (9%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: USPH underperformed the US Healthcare industry which returned 13.5% over the past year.
Return vs Market: USPH underperformed the US Market which returned 21% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is U.S. Physical Therapy's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 days ago | Simply Wall StAre Strong Financial Prospects The Force That Is Driving The Momentum In U.S. Physical Therapy, Inc.'s NYSE:USPH) Stock?
2 weeks ago | Simply Wall StHere's What To Make Of U.S. Physical Therapy's (NYSE:USPH) Returns On Capital
1 month ago | Simply Wall StAt US$113, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?
Is U.S. Physical Therapy undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: USPH ($127.82) is trading above our estimate of fair value ($102.25)
Significantly Below Fair Value: USPH is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: USPH is poor value based on its PE Ratio (54.4x) compared to the US Healthcare industry average (29.8x).
PE vs Market: USPH is poor value based on its PE Ratio (54.4x) compared to the US market (21.3x).
Price to Earnings Growth Ratio
PEG Ratio: USPH is poor value based on its PEG Ratio (3.5x)
Price to Book Ratio
PB vs Industry: USPH is overvalued based on its PB Ratio (6.2x) compared to the US Healthcare industry average (3.6x).
How is U.S. Physical Therapy forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: USPH's forecast earnings growth (15.6% per year) is above the savings rate (2%).
Earnings vs Market: USPH's earnings (15.6% per year) are forecast to grow slower than the US market (21.6% per year).
High Growth Earnings: USPH's earnings are forecast to grow, but not significantly.
Revenue vs Market: USPH's revenue (7.8% per year) is forecast to grow slower than the US market (10.2% per year).
High Growth Revenue: USPH's revenue (7.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: USPH's Return on Equity is forecast to be low in 3 years time (15.1%).
How has U.S. Physical Therapy performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: USPH has high quality earnings.
Growing Profit Margin: USPH's current net profit margins (7.1%) are higher than last year (6.3%).
Past Earnings Growth Analysis
Earnings Trend: USPH's earnings have grown by 8.4% per year over the past 5 years.
Accelerating Growth: USPH's earnings growth over the past year (1.4%) is below its 5-year average (8.4% per year).
Earnings vs Industry: USPH earnings growth over the past year (1.4%) underperformed the Healthcare industry 21.4%.
Return on Equity
High ROE: USPH's Return on Equity (11.3%) is considered low.
How is U.S. Physical Therapy's financial position?
Financial Position Analysis
Short Term Liabilities: USPH's short term assets ($82.6M) do not cover its short term liabilities ($93.2M).
Long Term Liabilities: USPH's short term assets ($82.6M) exceed its long term liabilities ($76.6M).
Debt to Equity History and Analysis
Debt Level: USPH's debt to equity ratio (6.3%) is considered satisfactory.
Reducing Debt: USPH's debt to equity ratio has reduced from 25.1% to 6.3% over the past 5 years.
Debt Coverage: USPH's debt is well covered by operating cash flow (356.2%).
Interest Coverage: USPH's interest payments on its debt are well covered by EBIT (28.5x coverage).
What is U.S. Physical Therapy current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate USPH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate USPH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if USPH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if USPH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: USPH is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of USPH's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Chris Reading (56 yo)
Mr. Christopher J. Reading, also known as Chris, has been the Chief Executive Officer and President of US Physical Therapy Inc. since November 1, 2004. Mr. Reading served as the Chief Operating Officer at ...
CEO Compensation Analysis
Compensation vs Market: Chris's total compensation ($USD2.85M) is about average for companies of similar size in the US market ($USD3.85M).
Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.
|Chief Operating Officer of West||16yrs||US$1.46m||0.11% |
|Chief Operating Officer of East||2.83yrs||US$1.55m||0.16% |
|Chief Financial Officer||0.17yr||no data||0.029% |
|General Counsel & Secretary||no data||no data||no data|
|VP & Corporate Controller||14.17yrs||no data||no data|
|Assistant Controller||no data||no data||no data|
Experienced Management: USPH's management team is seasoned and experienced (14.2 years average tenure).
|Independent Chairman||0.67yr||US$260.25k||0.056% |
|Independent Director||22.42yrs||US$241.00k||0.13% |
|Independent Director||15.92yrs||US$265.25k||0.079% |
|Independent Director||15.42yrs||US$247.25k||0.14% |
|Independent Director||2.67yrs||US$234.75k||0.048% |
|Independent Director||10.42yrs||US$260.25k||0.32% |
Experienced Board: USPH's board of directors are seasoned and experienced ( 14.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: USPH insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
U.S. Physical Therapy, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: U.S. Physical Therapy, Inc.
- Ticker: USPH
- Exchange: NYSE
- Founded: 1990
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: US$1.677b
- Shares outstanding: 12.85m
- Website: https://www.usph.com
Number of Employees
- U.S. Physical Therapy, Inc.
- 1300 West Sam Houston Parkway South
- Suite 300
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|USPH||NYSE (New York Stock Exchange)||Yes||Common Stock||US||USD||May 1992|
|UPH||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||May 1992|
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related i...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/01/15 23:07|
|End of Day Share Price||2021/01/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.